BlackRock Japan’s Alder Biopharmaceuticals ALDR Stock Holding History

BlackRock Japan’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$33K	Buy	1,574 +1,233	+362%	+$32.1K	﹤0.01%	1047
2016 Q3	$11K	Buy	341 +59	+21%	+$1.8K	﹤0.01%	1200
2016 Q2	$7K	Buy	+282	New	+$7.63K	﹤0.01%	1322
2016 Q1	–	Sell	-466	Closed	-$15K	–	1514
2015 Q4	$15K	Sell	466 -340	-42%	-$11.5K	﹤0.01%	1214
2015 Q3	$26K	Sell	806 -1,254	-61%	-$53.3K	﹤0.01%	1068
2015 Q2	$109K	Buy	2,060 +386	+23%	+$14K	﹤0.01%	957
2015 Q1	$48K	Hold	1,674	–	–	﹤0.01%	1070
2014 Q4	$49K	Sell	1,674 -2,240	-57%	-$40.2K	﹤0.01%	1103
2014 Q3	$50K	Buy	3,914 +470	+14%	+$7.1K	﹤0.01%	1057
2014 Q2	$69K	Buy	+3,444	New	+$48.5K	﹤0.01%	995

Other funds holding ALDR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock Japan's ALDR Position: Q4 2016 in Review

BlackRock Japan increased its Alder Biopharmaceuticals (ALDR) stake by 362% in Q4 2016, buying an estimated $32.1K and bringing the position to 1,574 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #1047.

BlackRock Japan first reported a position in ALDR in Q2 2014 and has held it in 10 quarters since. The position peaked at $109K in Q2 2015. 145 funds tracked by Wall St. Rank hold ALDR as of Q4 2016.

BlackRock Japan held 1,574 shares of Alder Biopharmaceuticals worth $33K as of Q4 2016.
BlackRock Japan bought 1,233 Alder Biopharmaceuticals shares in Q4 2016, an estimated $32.1K.
Alder Biopharmaceuticals made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1047 holding.
BlackRock Japan first reported a position in Alder Biopharmaceuticals in Q2 2014 and has held it in 10 quarters since.
BlackRock Japan's Alder Biopharmaceuticals position peaked at $109K in Q2 2015.
145 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.